CG
LLY icon

Caprock Group’s Eli Lilly LLY Stock Holding History

Caprock Group’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$61.6M Sell
67,008
-1,494
-2% -$1.51M 1.5% 10
2025
Q4 		$73.6M Buy
68,502
+6,808
+11% +$6.51M 1.56% 10
2025
Q3 		$45.3M Buy
+61,694
New +$45.9M 1.12% 13
2025
Q1 		$55.4M Sell
67,111
-3,314
-5% -$2.76M 1.69% 7
2024
Q4 		$54.4M Buy
70,425
+2,666
+4% +$2.21M 1.78% 7
2024
Q3 		$60M Buy
67,759
+8,051
+13% +$7.24M 2.18% 6
2024
Q2 		$54.1M Buy
59,708
+48,968
+456% +$39.2M 2.2% 7
2024
Q1 		$8.36M Buy
10,740
+804
+8% +$572K 0.48% 33
2023
Q4 		$5.79M Sell
9,936
-349
-3% -$204K 0.37% 43
2023
Q3 		$5.53M Buy
10,285
+159
+2% +$81.9K 0.42% 42
2023
Q2 		$4.75M Buy
10,126
+616
+6% +$258K 0.35% 46
2023
Q1 		$3.27M Buy
9,510
+727
+8% +$245K 0.25% 63
2022
Q4 		$3.21M Buy
8,783
+575
+7% +$204K 0.3% 50
2022
Q3 		$2.65M Buy
8,208
+401
+5% +$127K 0.26% 58
2022
Q2 		$2.53M Buy
7,807
+982
+14% +$295K 0.25% 60
2022
Q1 		$1.96M Buy
6,825
+100
+1% +$25.7K 0.18% 87
2021
Q4 		$1.86M Buy
6,725
+202
+3% +$51.2K 0.15% 96
2021
Q3 		$1.51M Buy
6,523
+1,157
+22% +$286K 0.13% 108
2021
Q2 		$1.23M Sell
5,366
-134
-2% -$26.9K 0.11% 133
2021
Q1 		$1.03M Sell
5,500
-248
-4% -$48.5K 0.11% 142
2020
Q4 		$970K Sell
5,748
-317
-5% -$47.3K 0.11% 142
2020
Q3 		$898K Buy
6,065
+758
+14% +$117K 0.12% 132
2020
Q2 		$871K Sell
5,307
-1,088
-17% -$167K 0.13% 125
2020
Q1 		$887K Sell
6,395
-131
-2% -$18K 0.17% 102
2019
Q4 		$858K Buy
6,526
+133
+2% +$15.4K 0.15% 111
2019
Q3 		$715K Sell
6,393
-690
-10% -$76.8K 0.14% 119
2019
Q2 		$785K Sell
7,083
-27
-0.4% -$3.18K 0.15% 119
2019
Q1 		$923K Sell
7,110
-2,375
-25% -$289K 0.18% 107
2018
Q4 		$1.1M Buy
9,485
+396
+4% +$44.2K 0.25% 84
2018
Q3 		$975K Sell
9,089
-85
-0.9% -$8.5K 0.2% 98
2018
Q2 		$783K Sell
9,174
-589
-6% -$48.4K 0.17% 116
2018
Q1 		$755K Sell
9,763
-1,224
-11% -$98.5K 0.16% 121
2017
Q4 		$956K Buy
10,987
+377
+4% +$32.1K 0.19% 110
2017
Q3 		$908K Buy
10,610
+1,583
+18% +$130K 0.19% 108
2017
Q2 		$743K Buy
9,027
+4,811
+114% +$393K 0.17% 128
2017
Q1 		$355K Sell
4,216
-12
-0.3% -$961 0.08% 217
2016
Q4 		$311K Buy
4,228
+973
+30% +$72.5K 0.08% 216
2016
Q3 		$261K Buy
3,255
+209
+7% +$16.7K 0.06% 278
2016
Q2 		$240K Buy
3,046
+91
+3% +$6.85K 0.06% 243
2016
Q1 		$213K Buy
+2,955
New +$224K 0.05% 297

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Caprock Group's LLY Position: Q1 2026 in Review

Caprock Group reduced its Eli Lilly (LLY) stake by 2.2% in Q1 2026, selling an estimated $1.51M and leaving 67,008 shares worth $61.6M. The position accounts for 1.5% of the portfolio, ranked #10.

Caprock Group first reported a position in LLY in Q1 2016 and has held it in 40 quarters since. The position peaked at $73.6M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Caprock Group held 67,008 shares of Eli Lilly worth $61.6M as of Q1 2026.
  • Caprock Group sold 1,494 Eli Lilly shares in Q1 2026, an estimated $1.51M.
  • Eli Lilly made up 1.5% of Caprock Group's portfolio in Q1 2026, its #10 holding.
  • Caprock Group first reported a position in Eli Lilly in Q1 2016 and has held it in 40 quarters since.
  • Caprock Group's Eli Lilly position peaked at $73.6M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Caprock Group's 13F filing for Q1 2026, filed 11 May 2026.